Recent Boston Scientific spin-off launches new products
Navilyst Medical, a manufacturer and marketer of vascular access and fluid management medical devices, has released its first new product launches as part of its newly branded entity from the divestiture from Boston Scientific.
The new products are being debuted about a month after the company’s introduction of its new corporate brand. The products are designed to contribute to a hospital’s compliance with OSHA regulations, CDC guidelines, as well as recently announced Joint Commission Hospital Patient Safety Goals, according to the Marlborough, Mass.-based company.
Navilyst said its customized peripherally inserted central catheters (PICC) kits now include the new Xcela Power Injectable PICC and an array of PICC insertion accessories and packaging.
Its new Xcela Power Injectable Ports will offer port options: the titanium Xcela ports, available in standard and low profile sizes, offer durability and reduced size and the plastic Xcela ports are light weight and offer radiolucence reduced imaging artifact, according to the company.
The new products are being debuted about a month after the company’s introduction of its new corporate brand. The products are designed to contribute to a hospital’s compliance with OSHA regulations, CDC guidelines, as well as recently announced Joint Commission Hospital Patient Safety Goals, according to the Marlborough, Mass.-based company.
Navilyst said its customized peripherally inserted central catheters (PICC) kits now include the new Xcela Power Injectable PICC and an array of PICC insertion accessories and packaging.
Its new Xcela Power Injectable Ports will offer port options: the titanium Xcela ports, available in standard and low profile sizes, offer durability and reduced size and the plastic Xcela ports are light weight and offer radiolucence reduced imaging artifact, according to the company.